Avalyn Pharma Inc IPO unlock schedule & public float
Lock-up schedule, public float and locked shares extracted from Avalyn Pharma Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Shares eligible to trade · by holder groupApr 30, 2026 → Oct 27, 2026 · 100% unlocked
Lock-up holders25.15M
IPO public float16.67M
About Avalyn Pharma Inc
Avalyn Pharma Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
Avalyn Pharma Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.
SEC IPO filings
Final prospectus
EDGAR filings resolved from AVLN / CIK 0001540171.
Avalyn Pharma reported first quarter 2026 financial results for the quarter ended March 31, 2026 and provided recent business highlights as a newly public company.
